APPLICATION
NDA017536
TYPE
NDA
ORIGINAL APPROVAL
1975-01-29
LATEST ACTION
2002-01-10
ROUTE
TOPICAL
DOSAGE FORM
CREAM
MARKETING STATUS
Discontinued
Products
DIPROSONEDiscontinued
BETAMETHASONE DIPROPIONATE EQ 0.05% BASE · CREAM · TOPICAL
Approval history
2002-01-10Manufacturing (CMC) · Supplement 25 · standardAP
1999-05-14Manufacturing (CMC) · Supplement 23 · standardAP
1998-12-07Manufacturing (CMC) · Supplement 21 · standardAP
1998-11-10Manufacturing (CMC) · Supplement 22 · standardAP
1998-07-31Manufacturing (CMC) · Supplement 20 · standardAP
1998-06-15Manufacturing (CMC) · Supplement 19 · standardAP
1990-08-01Manufacturing (CMC) · Supplement 17 · standardAP
1987-10-29Manufacturing (CMC) · Supplement 16 · standardAP
1986-09-12Manufacturing (CMC) · Supplement 15 · standardAP
1986-05-20Manufacturing (CMC) · Supplement 14 · standardAP
1986-04-23Manufacturing (CMC) · Supplement 13 · standardAP
1984-06-12Manufacturing (CMC) · Supplement 12 · standardAP
1982-07-21Efficacy · Supplement 9 · standardAP
1982-04-19Manufacturing (CMC) · Supplement 10 · standardAP
1981-10-13Manufacturing (CMC) · Supplement 6 · standardAP
1981-09-02Manufacturing (CMC) · Supplement 8 · standardAP
1980-06-03Manufacturing (CMC) · Supplement 3 · standardAP
1979-12-26Labeling · Supplement 5 · standardAP
1979-07-06Manufacturing (CMC) · Supplement 4 · standardAP
1978-09-29Labeling · Supplement 2 · standardAP
1975-03-17Labeling · Supplement 1 · standardAP
1975-01-29Type 2 - New Active Ingredient · Original · standardAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.